posted on 2016-11-15, 09:54authored byS. Yakkundi, Hussain Mulla, Hitesh Pandya, M. A. Turner, J. McElnay
AIM: Excipients are used to overcome the chemical, physical and microbiological challenges posed by developing formulated medicines. Both methyl and propyl paraben are commonly used in pediatric liquid formulations. There is no data on systemic exposure to parabens in neonates. The European Study of Neonatal Exposure to Excipients project has investigated this. Results & methodology: DBS sampling was used to collect opportunistic blood samples. Parabens were extracted from the DBS and analyzed using a validated LC-MS/MS assay. DISCUSSION & CONCLUSION: The above assay was applied to analyze neonatal DBS samples. The blood concentrations of parabens in neonates confirm systemic exposure to parabens following administration of routine medicines.
Funding
The work described here was funded under ERA-NET PRIOMEDCHILD programme. In the UK, this was funded by MRC Grant G1100158 to the Principal Investigator (MA Turner).
History
Citation
Bioanalysis, 2016, 8 (11), pp. 1173-1182
Author affiliation
/Organisation/COLLEGE OF MEDICINE, BIOLOGICAL SCIENCES AND PSYCHOLOGY/School of Medicine/Department of Infection, Immunity and Inflammation